STOCK TITAN

Hoth Therapeutics, Inc. (HOTH) Net Income by Year

HOTH

Hoth Therapeutics, Inc. reported a net loss of $12.5M in fiscal year 2025. This represents a decrease of 52.3% from the prior fiscal year. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Hoth Therapeutics, Inc. has filed alongside them.

FY2025 annual
Net Income -$12.5M
YoY -52.3%
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

HOTH Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY23FY22FY21FY20FY19FY18
Net Income-$12.5M-52.3%-$8.2M-1.0%-$8.1M+28.7%-$11.4M+20.6%-$14.3M-98.9%-$7.2M+6.6%-$7.7M-208.7%-$2.5M

HOTH Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'24Q4'23Q3'23Q2'23
Net Income-$2.7M+22.5%N/A-$4.1M-84.2%-$2.2M-28.6%-$3.5M-61.9%N/A-$2.2M-2.4%-$1.7M+9.8%-$2.1M+4.0%N/A-$2.2M+17.6%-$1.9M+29.2%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Hoth Therapeutics, Inc. financials

Frequently Asked Questions

What was Hoth Therapeutics, Inc.'s net income in fiscal year 2025?

Hoth Therapeutics, Inc. reported a net loss of $12.5M in fiscal year 2025.

How fast is Hoth Therapeutics, Inc.'s net income growing?

Hoth Therapeutics, Inc. (HOTH) net income fell by 52.3% year over year, from -$8.2M to -$12.5M in fiscal year 2025.

How has Hoth Therapeutics, Inc.'s net income changed over the years?

Across the 8 fiscal years this page covers, Hoth Therapeutics, Inc. (HOTH) net income went from -$2.5M in fiscal year 2018 to -$12.5M in fiscal year 2025.

Hoth Therapeutics, Inc. (HOTH) reported -$2.7M in net income in Q1 2026. This represents an increase of 22.5% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Hoth Therapeutics, Inc. (HOTH) reported on that line in every period on record.